Concepedia

Lukas M. Bollmann

LM

Statistics

Publications

2

Citations

47

H-Index

2

Active since

2022

Affiliations

Heinrich Heine University Düsseldorf(Current)

Lukas M. Bollmann is an author at Heinrich Heine University Düsseldorf specializing in radiation oncology, drug discovery, and drug resistance.

Top concepts

Publications per year

2022–2023

2

Publications

2

The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines

Lukas M. Bollmann, Alexander Jan Skerhut, Yodita Asfaha et al. · International Journal of Molecular Sciences · 2022 · 32 citations · Full text

5-(Trifluoromethyl)-1,2,4-oxadiazole (TFMO)-based highly selective class IIa HDAC inhibitors exhibit synergistic anticancer activity in combination with bortezomib

Yodita Asfaha, Lukas M. Bollmann, Alexander Jan Skerhut et al. · European Journal of Medicinal Chemistry · 2023 · 15 citations · Full text

, , +10

1–2 of 2